Elevance Health (ELV) Share-based Compensation (2009 - 2026)

Elevance Health (ELV) has reported Share-based Compensation for 18 consecutive years, with -$111.0 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Share-based Compensation fell 158.14% year-over-year to -$111.0 million in Q2 2026; TTM through Jun 2026 was $1.1 billion, a 215.58% increase from a year earlier, with the FY2025 full-year figure at $276.0 million, up 133.5% from the prior year.
• Share-based Compensation was -$111.0 million for Q2 2026 at Elevance Health, down from $1.6 billion in the prior quarter.
• Over five years, Share-based Compensation peaked at $1.6 billion in Q1 2026 and troughed at -$1.8 billion in Q4 2024.
• A 5-year average of $101.8 million and a median of $57.5 million in 2022 frame the typical range for Share-based Compensation.
• Across the five-year window, Share-based Compensation soared 667.92% in 2023 and slumped 573.56% in 2024, its largest moves.
• Over 5 years, Share-based Compensation stood at -$201.0 million in 2022, then decreased by 29.85% to -$261.0 million in 2023, then tumbled by 573.56% to -$1.8 billion in 2024, then jumped by 92.78% to -$127.0 million in 2025, then advanced by 12.6% to -$111.0 million in 2026.
• The last three Share-based Compensation figures came in at -$111.0 million (Q2 2026), $1.6 billion (Q1 2026), and -$127.0 million (Q4 2025), per Business Quant data.